You are here

Home » Content

Safra Kesesi Kanserlerinde Displazi ve Nöroendokrin Diferansiyasyon

Dysplasia and neuroendocrine differentiation in gallbladder carcinomas

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1997

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
In this study, 8 gallbladder carcinomas among 435 cholecystectomy specimens which were examined in the Pathology Department of İnönü University Medical School, between 1992 and 1996, were reviewed. In microscopic examination, three mucinous carcinomas, three well and one moderately differentiated adenocarcinomas and one adenosquamous cell carcinoma were seen. Dysplasia was detected in two cases adjacent to tumor tissues. Five cases had stage V, 1 had stage IV and, 2 had stage III tumors. Tumor cells were focally positive for Chromogranin-A in 2 adenocarcinomas and 2 mucinous carcinomas. Although it is reported that neuroendocrine differentiation has no effect on prognosis of gallbladder carcinoma, the number of Chromogranin-A positive cases was more common in advanced stage tumors in our study. [Journal of Turgut Özal Medical Center 1997;4(1):116-119]
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışmada 1992-1996yılları arasında, İnönü Üniversitesi Tıp Fakültesi Patoloji Anabilim Dalı'nda 435 safra kesesi materyalinde saptadığımız 8 safra kesesi karsinomu gözden geçirildi. Mikroskobik incelemede 3 müsinöz karsinom, 3 iyi ve 1 orta diferansiye adenokarsinom ile 1 adenoskuamöz karsinom görüldü. İki olguda tümör komşuluğunda displazi saptandı. Olguların 5 'i evre V, 1 'i evre IV ve 2 'si evre III idi. iki adenokarsinom ve 2 müsinöz karsinom olgusunda tümör hücrelerinde Kromogranin-A ile fokal pozitiflik vardı. Nöroendokrin diferansiyasyonun safra kesesi karsinomlarında prognoza etkili olmadığı bildirilmesine rağmen çalışmamızda ileri evredeki tümörler arasında Kromogranin-A ile pozitif olgu sayısı daha fazla bulundu. [Turgut Özal Tıp Merkezi Dergisi 1997;4(1): 116-119
FULL TEXT (PDF): 
PDF icon arastirmax-safra-kesesi-kanserlerinde-displazi-noroendokrin-diferansiyasyon.pdf
  • 1
116-119
  • Turkish

REFERENCES

References: 

1. Henson DE, Saavedra JA, Corle D. Carcinoma of the gallbladder. Cancer 1992; 70:1493- 97.
2. Duarte I, Llanos O, Domke H, et al. Metaplasia and precursor lesions of gallbladder carcinoma. Cancer
1993;72:1878-84.
3. Saul SH. Gallbladder and extrahepatic biliary tree. In: Sternberg SS, ed. Diagnostic Surgical Pathology, 2nd ed. New York: Raven Press 1994:1581-612.
4. Yohonda MA. Hepatobiliary cancers In: Berger DH, Feig BW, Fuhrman GM, eds. The MD Anderson Surgical Oncology Handbook. Boston: Little, Brown and Company
1995:195-223.
5. Saavedra JA, Henson DE, Sobin LH. The WHO histological classification of tumors of the gallbladder and extrahepatic
bile ducts. Cancer 1992;70:410-14.
6. di Santagnese PA, de Mesy Jensen KL. Neuroendocrine differentiation in prostatic carcinoma. Hum Pathol
1987;18:849-56.
7. Frierson HF. Gallbladder and extrahepatic biliary system. In: Sternberg SS, ed. Histology for Pathologists. Raven Press. New York 1992:639-56.
8. Nevin JE, Moran TJ, Kay S, King R. Carcinoma of Gallbladder. Cancer 1976;37:141-48.
9. Shirai Y, Tsukada K, Ohtani T, et al. Hepatic metastases from carcinoma of the gallbladder. Cancer 1995;75:2063-8.
10. 10.Johnstone AK, Zuch RH, Anders KH. Oat cell carcinoma of the gallbladder. Arch Pathol Lab Med 1993;117:1009-12.

Thank you for copying data from http://www.arastirmax.com